Icu Medical Inc. (ICUI) fundamentals score
ICU develops, manufactures and sells innovative medical products used in infusion therapy, vascular access, and vital care applications. Its team is focused on providing quality, innovation and value to its clinical customers worldwide.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 7.1 out of 10, Good long-term fundamentals
- Growth: 6.1/10
- Profitability: 6.9/10
- Financial health: 9.5/10
- Earnings quality: 8.9/10
- Valuation: 4.4/10
Scores are calculated from Icu Medical Inc.’s SEC filings, using the 12 months through 2021-09. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10